Andrew Shelton, MD
General Surgery · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 3 carriers
- Offices
- 3
- Since medical school
- 35 years
- University of Wisconsin School of Medicine, 1991
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
14 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shelton’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G76692 · Current
Licensed to practise in California · since 1993 · expires 2028-09-30 · University of Wisconsin Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$113,876
Medicare paid this office $113,876 for 214 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Partial removal of small and large bowel with attachment of small and large bowel using an endoscope | 11 | $12,764 | $1,160 |
| New patient visit (60+ min) | 27 | $4,258 | $158 |
| New patient visit (45+ min) | 23 | $2,516 | $109 |
| Short return visit | 44 | $1,786 | $29 |
| Diagnostic exam of lower portion of large bowel using a flexible endoscope | 21 | $1,691 | $50 |
See all 12 services
| Partial removal of small and large bowel with attachment of small and large bowel using an endoscope | 11 | $12,764 | $1,160 |
| New patient visit (60+ min) | 27 | $4,258 | $158 |
| New patient visit (45+ min) | 23 | $2,516 | $109 |
| Short return visit | 44 | $1,786 | $29 |
| Diagnostic exam of lower portion of large bowel using a flexible endoscope | 21 | $1,691 | $50 |
| Short return visit (20+ min) | 28 | $1,629 | $53 |
| Long return visit (40+ min) | 12 | $1,568 | $131 |
| New patient visit (30+ min) | 19 | $1,393 | $73 |
| Return visit (30+ min) | 13 | $1,143 | $88 |
| Short return visit (20+ min) | 11 | $1,018 | $78 |
| Short return visit | 16 | $889 | $52 |
| Diagnostic exam of anus using an endoscope | 11 | $630 | $31 |
Procedures Medicare counted
| Colonoscopy | 48 | More than 63% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Diagnostic exam of lower portion of large bowel using a flexible endoscope | – | – | 21 | 29 | 25 | 34 |
| Partial release of large bowel and partial removal of large bowel using an endoscope | – | – | 12 | 13 | 14 | – |
| Partial removal of small and large bowel with attachment of small and large bowel using an endoscope | – | – | 14 | – | 12 | 11 |
| Diagnostic exam of rectum and lower large bowel using an endoscope | 11 | 15 | – | – | – | – |
| Diagnostic exam of anus using an endoscope | – | – | – | – | – | 20 |
| Partial removal of large bowel and reattachment to rectum using an endoscope | – | – | – | – | 13 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
214 Original Medicare patients in 2024. Average age 73 · Under 65 8% · 85 and older 8% · Women 46% · Also on Medicaid 31% · Health risk score 1.71. Above the middle of the specialty; the typical general surgery clinician is at 1.69.
Conditions among them: Cancer 70% · High blood pressure 68% · Diabetes 27% · Coronary heart disease 27% · Chronic kidney disease 18% · Depression 18% · Atrial fibrillation 17% · Heart failure 14% · COPD 10% · Dementia 7%.
The office billed $680,577, Medicare allowed $144,351 and paid $113,876; for 454 services of 65 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 214 | 454 | 73 | 1.71 | $680,577 | $113,876 |
| 2023 | 203 | 461 | 73 | 1.85 | $798,796 | $129,509 |
| 2022 | 210 | 450 | 73 | 1.78 | $643,363 | $108,601 |
| 2021 | 196 | 442 | 72 | 1.58 | $778,437 | $138,318 |
| 2020 | 165 | 353 | 72 | 1.70 | $645,206 | $109,439 |
| 2019 | 210 | 439 | 72 | 1.70 | $821,193 | $139,505 |
| 2018 | 209 | 445 | 72 | 1.93 | $795,666 | $131,537 |
| 2017 | 213 | 400 | 71 | 1.55 | $726,191 | $118,821 |
| 2016 | 268 | 519 | 72 | 1.84 | $1,010,720 | $172,319 |
| 2015 | 198 | 373 | 71 | 1.62 | $724,552 | $124,616 |
| 2014 | 178 | 348 | 71 | 1.79 | $634,324 | $114,544 |
| 2013 | 209 | 386 | 72 | 1.64 | $566,276 | $99,677 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Partial removal of large bowel and reattachment to rectum using an endoscope | 13 | $20,057 | $1,543 |
| Partial removal of small and large bowel with attachment of small and large bowel using an endoscope | 12 | $14,133 | $1,178 |
| New patient visit (45+ min) | 31 | $3,559 | $115 |
| New patient visit (60+ min) | 17 | $2,597 | $153 |
| Short return visit (20+ min) | 37 | $2,301 | $55 |
| Partial release of large bowel and partial removal of large bowel using an endoscope | 14 | $2,270 | $162 |
| Short return visit | 48 | $2,026 | $30 |
| Return visit (30+ min) | 21 | $1,838 | $84 |
| New patient visit (30+ min) | 25 | $1,557 | $62 |
| Diagnostic exam of lower portion of large bowel using a flexible endoscope | 15 | $1,278 | $51 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 18 | $71 | $4 |
2022: 9 services
| New patient visit (60+ min) | 29 | $5,335 | $184 |
| New patient visit (45+ min) | 27 | $3,473 | $129 |
| Short return visit (20+ min) | 38 | $2,662 | $62 |
| Short return visit | 50 | $2,144 | $30 |
| Partial release of large bowel and partial removal of large bowel using an endoscope | 13 | $2,137 | $164 |
| Return visit (30+ min) | 16 | $1,623 | $101 |
| Biopsy of large bowel using a flexible endoscope | 12 | $1,599 | $133 |
| New patient visit (30+ min) | 20 | $1,489 | $74 |
| Diagnostic exam of lower portion of large bowel using a flexible endoscope | 19 | $1,419 | $49 |
2021: 9 services
| Partial removal of small and large bowel with attachment of small and large bowel using an endoscope | 14 | $17,040 | $1,217 |
| New patient visit (60+ min) | 29 | $5,716 | $197 |
| New patient visit (45+ min) | 40 | $5,498 | $137 |
| Return visit (30+ min) | 22 | $2,275 | $103 |
| Partial release of large bowel and partial removal of large bowel using an endoscope | 12 | $1,999 | $167 |
| Short return visit | 47 | $1,844 | $30 |
| New patient visit (30+ min) | 23 | $1,783 | $78 |
| Short return visit (20+ min) | 31 | $1,775 | $52 |
| Diagnostic exam of lower portion of large bowel using a flexible endoscope | 14 | $1,095 | $52 |
2020: 8 services
| New patient visit (45+ min) | 33 | $3,768 | $114 |
| New patient visit (60+ min) | 16 | $2,636 | $165 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,597 | $133 |
| Short return visit (20+ min) | 27 | $1,481 | $46 |
| Return visit (30+ min) | 17 | $1,380 | $77 |
| New patient visit (30+ min) | 16 | $1,076 | $67 |
| Short return visit | 30 | $847 | $23 |
| Diagnostic exam of rectum and lower large bowel using an endoscope | 15 | $385 | $26 |
2019: 9 services
| Closure of surgically created large or small bowel opening with bowel removal and reattachment | 13 | $10,776 | $829 |
| New patient visit (45+ min) | 41 | $4,445 | $108 |
| New patient visit (60+ min) | 25 | $3,356 | $134 |
| New patient visit (30+ min) | 26 | $1,771 | $68 |
| Short return visit (20+ min) | 32 | $1,547 | $44 |
| Long return visit (40+ min) | 11 | $1,111 | $101 |
| Return visit (30+ min) | 14 | $1,077 | $72 |
| Short return visit | 34 | $855 | $21 |
| Diagnostic exam of rectum and lower large bowel using an endoscope | 11 | $247 | $22 |
2018: 10 services
| Partial removal of large bowel using an endoscope | 11 | $14,854 | $1,350 |
| New patient visit (60+ min) | 34 | $4,830 | $142 |
| New patient visit (45+ min) | 28 | $2,989 | $107 |
| Short return visit (20+ min) | 35 | $1,795 | $45 |
| New patient visit (30+ min) | 31 | $1,729 | $56 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,701 | $155 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,344 | $122 |
| Return visit (30+ min) | 21 | $1,298 | $59 |
| Short return visit | 50 | $1,157 | $20 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 17 | $82 | $5 |
2017: 8 services
| New patient visit (45+ min) | 38 | $4,158 | $109 |
| New patient visit (60+ min) | 18 | $2,640 | $147 |
| Diagnostic exam of large bowel using a flexible endoscope | 13 | $2,066 | $159 |
| New patient visit (30+ min) | 29 | $1,958 | $68 |
| Return visit (30+ min) | 20 | $1,481 | $71 |
| Short return visit (20+ min) | 31 | $1,369 | $41 |
| Short return visit | 49 | $1,272 | $21 |
| New patient visit (15+ min) | 25 | $1,087 | $43 |
2016: 11 services
| Partial removal of large bowel and reattachment to rectum using an endoscope | 13 | $19,657 | $1,512 |
| Closure of surgically created large or small bowel opening with bowel removal and reattachment | 12 | $9,693 | $808 |
| New patient visit (45+ min) | 34 | $3,922 | $115 |
| New patient visit (60+ min) | 31 | $3,548 | $114 |
| New patient visit (30+ min) | 49 | $3,072 | $63 |
| Partial release of large bowel and partial removal of large bowel using an endoscope | 14 | $2,215 | $158 |
| Short return visit (20+ min) | 38 | $1,754 | $42 |
| Short return visit | 53 | $1,406 | $21 |
| Return visit (30+ min) | 20 | $1,261 | $63 |
| Release of large bowel from spleen and abdominal wall with partial removal of large bowel | 11 | $1,146 | $104 |
| New patient visit (15+ min) | 27 | $1,121 | $42 |
2015: 10 services
| Partial removal of large bowel using an endoscope | 11 | $14,863 | $1,351 |
| New patient visit (60+ min) | 40 | $5,650 | $141 |
| New patient visit (45+ min) | 25 | $2,863 | $115 |
| Partial release of large bowel and partial removal of large bowel using an endoscope | 11 | $1,798 | $163 |
| New patient visit (30+ min) | 28 | $1,725 | $62 |
| Long return visit (40+ min) | 17 | $1,690 | $99 |
| Short return visit (20+ min) | 27 | $1,273 | $42 |
| Short return visit | 32 | $749 | $21 |
| Return visit (30+ min) | 11 | $702 | $58 |
| New patient visit (15+ min) | 13 | $313 | $24 |
2014: 9 services
| New patient visit (45+ min) | 25 | $2,890 | $116 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,158 | $180 |
| New patient visit (60+ min) | 13 | $1,944 | $150 |
| New patient visit (30+ min) | 22 | $1,353 | $61 |
| Short return visit (20+ min) | 29 | $1,273 | $41 |
| Return visit (30+ min) | 17 | $1,120 | $66 |
| Short return visit | 34 | $937 | $21 |
| New patient visit (15+ min) | 13 | $492 | $38 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $108 | $7 |
2013: 7 services
| New patient visit (60+ min) | 36 | $5,121 | $142 |
| New patient visit (45+ min) | 14 | $1,583 | $113 |
| New patient visit (30+ min) | 25 | $1,437 | $57 |
| Short return visit | 55 | $1,254 | $19 |
| Short return visit (20+ min) | 18 | $837 | $42 |
| New patient visit (15+ min) | 15 | $570 | $38 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 25 | $181 | $6 |
Drugs they prescribed that Part D paid
$4,392
Pharmacies billed $4,392 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
248 generic and 25 brand-name prescriptions · $4,392 in drug cost · 140 antibiotic prescriptions to 70 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Sod Sulf-Potass Sulf-Mag Sulf | 11 | $748 | $68 |
| Gavilyte-G | 51 | $691 | $14 |
| Neomycin Sulfate | 70 | $323 | $5 |
| Peg-3350 and Electrolytes | 18 | $238 | $13 |
| Metronidazole | 69 | $87 | $1 |
Year by year
| 2024 | 273 | 93 | None | 9% | $4,392 |
| 2023 | 271 | 91 | None | 18% | $9,225 |
| 2022 | 235 | 77 | None | 30% | $12,802 |
| 2021 | 293 | 89 | None | 26% | $21,414 |
| 2020 | 194 | 68 | None | 16% | $8,589 |
| 2019 | 251 | 84 | None | 14% | $9,375 |
| 2018 | 354 | 108 | None | None | $21,567 |
| 2017 | 318 | 93 | 7% (21) | None | $8,889 |
| 2016 | 279 | 109 | 13% (36) | None | $9,789 |
| 2015 | 184 | 66 | 16% (29) | 15% | $21,094 |
| 2014 | 249 | 67 | 23% (58) | 17% | $16,913 |
| 2013 | 170 | 67 | 32% (55) | 12% | $7,108 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Enoxaparin | 13 | $1,843 | $142 |
| Lactated Ringers | 27 | $1,548 | $57 |
| Sod Sulf-Potass Sulf-Mag Sulf | 19 | $1,505 | $79 |
| Gavilyte-G | 49 | $792 | $16 |
| Neomycin Sulfate | 53 | $338 | $6 |
| Metronidazole | 59 | $112 | $2 |
2022: 7 drugs
| Suprep | 28 | $3,191 | $114 |
| Enoxaparin | 12 | $1,443 | $120 |
| Lactated Ringers | 18 | $719 | $40 |
| Gavilyte-G | 22 | $297 | $13 |
| Neomycin Sulfate | 33 | $183 | $6 |
| Peg-3350 and Electrolytes | 12 | $149 | $12 |
| Metronidazole | 49 | $90 | $2 |
2021: 8 drugs
| Caspofungin Acetate | 15 | $5,016 | $334 |
| Smoflipid | 11 | $4,127 | $375 |
| Suprep | 35 | $3,868 | $111 |
| Meropenem | 16 | $3,378 | $211 |
| Enoxaparin | 15 | $1,827 | $122 |
| Neomycin Sulfate | 55 | $320 | $6 |
| Peg-3350 and Electrolytes | 19 | $249 | $13 |
| Metronidazole | 55 | $110 | $2 |
2020: 4 drugs
| Gavilyte-C | 17 | $225 | $13 |
| Neomycin Sulfate | 36 | $202 | $6 |
| Gavilyte-G | 14 | $153 | $11 |
| Metronidazole | 37 | $102 | $3 |
2019: 6 drugs
| Suprep | 11 | $1,089 | $99 |
| Gavilyte-G | 49 | $680 | $14 |
| Neomycin Sulfate | 41 | $226 | $6 |
| Metronidazole | 47 | $193 | $4 |
| Ondansetron Odt | 11 | $177 | $16 |
| Gabapentin | 11 | $106 | $10 |
2018: 8 drugs
| Diphenoxylate-Atropine | 13 | $1,225 | $94 |
| Suprep | 12 | $1,112 | $93 |
| Gavilyte-G | 41 | $473 | $12 |
| Neomycin Sulfate | 57 | $324 | $6 |
| Peg-3350 and Electrolytes | 23 | $258 | $11 |
| Metronidazole | 59 | $161 | $3 |
| Ondansetron Odt | 13 | $123 | $9 |
| Gabapentin | 13 | $71 | $5 |
2017: 7 drugs
| Diphenoxylate-Atropine | 17 | $1,806 | $106 |
| Suprep | 12 | $1,056 | $88 |
| Gavilyte-G | 22 | $283 | $13 |
| Peg-3350 and Electrolytes | 25 | $272 | $11 |
| Neomycin Sulfate | 44 | $264 | $6 |
| Metronidazole | 46 | $114 | $2 |
| Gabapentin | 14 | $94 | $7 |
2016: 9 drugs
| Diphenoxylate-Atropine | 21 | $1,880 | $90 |
| Polyethylene Glycol 3350 | 11 | $508 | $46 |
| Hydrocodone-Acetaminophen | 22 | $311 | $14 |
| Gavilyte-G | 16 | $268 | $17 |
| Gabapentin | 14 | $181 | $13 |
| Peg-3350 and Electrolytes | 15 | $171 | $11 |
| Neomycin Sulfate | 27 | $168 | $6 |
| Metronidazole | 29 | $93 | $3 |
| Oxycodone | 11 | $92 | $8 |
2015: 5 drugs
| Diphenoxylate-Atropine | 25 | $2,045 | $82 |
| Lidocaine | 11 | $1,673 | $152 |
| Dorzolamide-Timolol | 13 | $946 | $73 |
| Tamsulosin | 11 | $160 | $15 |
| Acetaminophen-Codeine | 15 | $123 | $8 |
2014: 6 drugs
| Diphenoxylate-Atropine | 26 | $1,342 | $52 |
| Polyethylene Glycol 3350 | 16 | $918 | $57 |
| Lidocaine | 13 | $756 | $58 |
| Hydrocodone-Acetaminophen | 37 | $523 | $14 |
| Peg-3350 and Electrolytes | 12 | $173 | $14 |
| Acetaminophen-Codeine | 16 | $146 | $9 |
2013: 2 drugs
| Diphenoxylate-Atropine | 26 | $876 | $34 |
| Hydrocodone-Acetaminophen | 46 | $726 | $16 |
Money from drug and device companies
$120 in 2024
| 2024 | 1 | 1 | None | $120 |
| 2023 | 1 | 1 | None | $126 |
| 2019 | 1 | 8 | None | $2,120 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ethicon US | Echelon Circular | $120 | 1 payment
|
See the published payment
| Ethicon US | Meals · 2024-10-31 | Echelon Circular | $120 |
See earlier years (2023, 2019)
2023: $126
| Cook Biotech | None | $126 | 1 payment
|
2019: $2,120
| Intuitive Surgical | Da Vinci Surgical System | $2,120 | 8 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1710029681
- Licence
- CA G76692California G76692: Current · expires 2028-09-30
- Trained
- University of Wisconsin School of Medicine, 1991 · 35 years ago
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G76692
- Taxonomy
- Federal specialty code 208C00000X (208C00000X)
- Mailing address
- 300 Pasteur Dr # H3680, Stanford, CA, 94305
- NPI first listed
- 2007-02-13
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.